2q37 deletion syndrome is a rare chromosomal condition caused by a missing segment at the tip of the long arm of chromosome 2, and it affects multiple body systems in ways that range from subtle to severe. The syndrome is sometimes called brachydactyly-mental retardation syndrome because shortened fingers and developmental delays are among its most recognizable features. The primary genetic driver appears to be loss of the HDAC4 gene, though the size and exact location of the deletion shape what each person actually experiences. Because no two deletions are identical, understanding the syndrome means understanding a spectrum rather than a single fixed picture.
The Genetic Basis
The syndrome arises from a deletion on the distal (far end) portion of chromosome 2, in a region labeled 2q37. The deletions vary in size, with most spanning somewhere between about 2 and 9 megabases of DNA. Research narrowing down the critical region has identified one gene in particular, HDAC4, as the primary contributor. HDAC4 encodes a protein involved in regulating how other genes are turned on and off, and losing one working copy of it appears to drive most of the hallmark features of the syndrome.
1PubMed Central. Haploinsufficiency of HDAC4 causes brachydactyly mental retardation syndrome, with brachydactyly type E, developmental delays, and behavioral problemsThat said, not everyone with a 2q37 deletion has the same clinical outcome, even when HDAC4 is included in the deleted segment. A study of 103 individuals with the syndrome found that the penetrance of features is incomplete, meaning some people missing the gene still do not develop certain expected traits.2PubMed. Genotype and phenotype correlation in 103 individuals with 2q37 deletion syndrome reveals incomplete penetrance and supports HDAC4 as the primary genetic contributor This incomplete penetrance is one reason families sometimes struggle to get a clear prognosis after a diagnosis.
There is also evidence that deletions beyond HDAC4, farther toward the chromosome tip, can contribute their own set of clinical features. One case involved a child carrying the smallest known 2q37.3 deletion that did not even include HDAC4, yet the child still had language delay, behavioral issues, mild facial differences, and brachydactyly. Researchers pointed to a neighboring region containing the HDLBP gene as a possible contributor to features that overlap with the broader syndrome.3Cytogenetic and Genome Research. Genotype-Phenotype Correlation of Distal 2q37 Deletions This suggests that while HDAC4 is the main actor, it is not the only gene in the region that matters.
Physical Features and Facial Appearance
Children with 2q37 deletion syndrome often share a set of recognizable facial features, though the combination and severity differ from person to person. Commonly described features include a flat nasal bridge, deep-set eyes, arched eyebrows, a thin upper lip, and ear differences.4Annals of Pediatric Endocrinology & Metabolism. 2q37 Deletion syndrome confirmed by high-resolution cytogenetic analysis In one review of nine patients, facial dysmorphism was present in every single case.5PubMed Central. Genotype-Phenotype Correlations in 2q37-Deletion Syndrome: An Update of the Clinical Spectrum and Literature Review These features are individually mild and may not be immediately obvious, particularly in infancy, which is part of why some children go undiagnosed until developmental concerns prompt genetic testing.
Some affected children also have macrocephaly, a head circumference larger than average. A case report of a three-year-old Colombian child with the syndrome documented macrocephaly alongside hypotonia and speech delay, though brain imaging was normal.6PubMed Central. 2q37 deletion syndrome in a Colombian patient with macrocephaly: a case report The takeaway for families is that a large head size in the context of other features can be a useful clue for clinicians, but does not by itself indicate structural brain abnormalities.
Brachydactyly and Skeletal Involvement
Brachydactyly type E, a shortening of the hand and foot bones (particularly the metacarpals and metatarsals), is one of the most distinctive skeletal features of 2q37 deletion syndrome. It is common enough that it helped give the syndrome its alternative name. In the same nine-patient review mentioned above, skeletal anomalies were present in eight out of nine individuals, with brachydactyly type E being the most frequent finding.5PubMed Central. Genotype-Phenotype Correlations in 2q37-Deletion Syndrome: An Update of the Clinical Spectrum and Literature Review Short stature is also reported in some cases.
The skeletal picture is interesting because it can exist on its own, without the intellectual disability that usually accompanies the syndrome. The first reported familial case of an inherited 2q37.3 deletion involved family members who had brachydactyly type E and short stature but no intellectual disability. Their deletion affected both HDAC4 and a neighboring gene called TWIST2, yet the cognitive features that typically come with the syndrome were absent.7PubMed. The first familial case of inherited 2q37.3 interstitial deletion with isolated skeletal abnormalities including brachydactyly type E and short stature This reinforces the idea that HDAC4 loss produces a wide spectrum of outcomes. For clinicians, it means a patient with unexplained brachydactyly type E might warrant genetic testing for a 2q37 deletion even if developmental milestones seem on track.
Developmental and Behavioral Features
Most children with 2q37 deletion syndrome experience some degree of developmental delay, particularly in speech and language. Global developmental delay and intellectual disability were present in eight out of nine cases in one recent literature review, and behavioral disorders were noted in more than half.5PubMed Central. Genotype-Phenotype Correlations in 2q37-Deletion Syndrome: An Update of the Clinical Spectrum and Literature Review Hypotonia, or low muscle tone, is another frequent early sign and often compounds motor delays.
Autism spectrum features are strikingly common. In a study of eight children with the syndrome who were evaluated using the Childhood Autism Rating Scale, five (about 63%) scored within the autism spectrum range. Scores varied widely, from well below the autism threshold to the severely affected range.8PubMed. Deletion 2q37 syndrome: Cognitive-behavioral trajectories and autistic features related to breakpoint and deletion size That wide spread matters for families: receiving a 2q37 deletion diagnosis does not predict exactly where a child will fall on the behavioral spectrum. Early developmental assessments and autism-specific screening can help guide what interventions are likely to be most useful.
Language delay tends to be one of the first concerns that brings families to medical attention. Expressive language (producing speech) is often more affected than receptive language (understanding speech), though both can be delayed. One case series noted that deletion size and breakpoint location seemed to influence the severity of cognitive and behavioral outcomes, with larger deletions generally being associated with more pronounced delays.8PubMed. Deletion 2q37 syndrome: Cognitive-behavioral trajectories and autistic features related to breakpoint and deletion size However, there is enough individual variation that size alone does not predict a child’s trajectory with confidence.
Heart, Kidney, and Other Organ Involvement
2q37 deletion syndrome is not limited to bones and behavior. Abnormalities affecting the heart, kidneys, eyes, and gastrointestinal system have been noted in close to a third of patients overall.9PubMed. Chromosome 2q37 deletion: clinical and molecular aspects Congenital heart defects are among the more medically significant complications. One detailed case report described an eight-month-old boy with the syndrome who had atrial and ventricular septal defects, a patent ductus arteriosus, and obstruction of the right ventricular outflow tract, all of which required surgical repair with a complicated postoperative course.10PubMed. From diagnosis to postoperative challenges: a comprehensive case report on 2q37 deletion syndrome with CHD Narrowing or underdevelopment of the aorta has also been described in several affected children.
Less dramatic cardiac findings are possible too. A case of a three-year-old girl with the syndrome documented a patent foramen ovale, a small opening between the heart’s upper chambers that sometimes closes on its own. That same child showed improvement in hypotonia and gross motor delay after a year of physical therapy, illustrating that even when organ involvement is present, functional gains are still achievable with targeted intervention.11PubMed Central. A rare case of 2q37 deletion syndrome presented with patent foramen ovale
Kidney and gastrointestinal issues, including renal dysplasia, cystic kidneys, pyloric stenosis, and diaphragmatic defects, have been reported across the range of breakpoint locations. Some features appear to cluster with specific breakpoints: Wilms tumor, renal dysplasia, and tracheomalacia have been reported mostly when the deletion extends to band 2q37.1, the most proximal breakpoint in the region.9PubMed. Chromosome 2q37 deletion: clinical and molecular aspects Seizures and cystic kidneys are also described as features that may emerge later in childhood rather than being present at birth.
Wilms Tumor Risk
One question that understandably worries families is whether a 2q37 deletion raises the risk of cancer. Research has identified a region at 2q37.1 that likely contains a tumor suppressor gene, and loss of this region in tumor tissue has been linked to Wilms tumor, a kidney cancer that primarily affects young children.12PubMed Central. Loss of heterozygosity at 2q37 in sporadic Wilms tumor: a putative role for miR-562 However, a cohort study looking specifically at Wilms tumor rates among individuals with 2q terminal deletions concluded that the overall incidence is low and falls below the threshold that would typically justify routine tumor surveillance.13American Journal of Medical Genetics. Part A. Wilms tumor incidence in children with 2q terminal deletions: A cohort study
The practical implication is that while the theoretical mechanism for increased risk exists, the actual observed risk in children with 2q37 deletions has not been high enough to warrant formal screening programs like those used for other deletion syndromes with well-established tumor predisposition. Families should discuss this with their geneticist, particularly if their child’s deletion extends proximally to include band 2q37.1, since the tumor suppressor region is located there. For most children with the syndrome, however, the kidney cancer risk is not a primary clinical concern.
Why It Gets Confused with Pseudohypoparathyroidism
One of the trickiest aspects of diagnosing 2q37 deletion syndrome is that it can look a great deal like Albright hereditary osteodystrophy, a condition caused by mutations in a completely different gene called GNAS. Both conditions can produce short stature, brachydactyly, a round face, and developmental differences. Adding to the confusion, some individuals with 2q37 deletions have been found to have biochemical signs of resistance to parathyroid hormone, a hallmark of classic pseudohypoparathyroidism. While only a handful of such cases have been documented, this overlap greatly increases the chance of misdiagnosis.14PubMed. Novel 4.18 Mb deletion resulting in 2q37 microdeletion syndrome combined with PTH resistance found in one Chinese patient
The distinction matters because management differs. Pseudohypoparathyroidism caused by GNAS mutations requires specific endocrine monitoring and calcium management, while 2q37 deletion syndrome calls for a broader surveillance approach that includes developmental, cardiac, and skeletal assessments. Genetic testing with chromosomal microarray is the clearest path to distinguishing the two. When a child presents with features suggestive of Albright hereditary osteodystrophy but GNAS testing comes back normal, a 2q37 deletion should be on the differential.
Managing Care Across Multiple Systems
Because 2q37 deletion syndrome touches so many body systems, care typically involves a team of specialists. No single treatment addresses the syndrome itself; instead, management focuses on each affected system individually. For the developmental and behavioral features, early intervention services are the backbone. Speech therapy for language delays, occupational therapy for fine motor and sensory challenges, and physical therapy for hypotonia and gross motor delays are all standard components of care. As noted in one case, a year of physical therapy led to meaningful improvement in motor skills even in a child who also had a cardiac finding.11PubMed Central. A rare case of 2q37 deletion syndrome presented with patent foramen ovale
Cardiac evaluation, usually with echocardiography, is recommended at or near the time of diagnosis given that congenital heart defects occur in a meaningful fraction of affected individuals. Renal ultrasound is also reasonable, particularly for children with more proximal deletions. Endocrine evaluation may be warranted to check for calcium and parathyroid hormone abnormalities, especially when the clinical picture overlaps with pseudohypoparathyroidism. Ophthalmologic evaluation can catch the ocular anomalies reported in some patients.
Timely diagnosis matters in a practical way beyond just knowing the name of the condition. A confirmed genetic diagnosis helps families avoid an expensive and frustrating diagnostic odyssey, guides which specialists need to be involved, and provides a framework for genetic counseling about recurrence risk in future pregnancies.9PubMed. Chromosome 2q37 deletion: clinical and molecular aspects
The Question of Inheritance
Most 2q37 deletions arise de novo, meaning they are new events in the child and were not present in either parent’s genome. This is the most common scenario, and in these cases the recurrence risk for future siblings is low, though not zero because of the small possibility of germline mosaicism in a parent.
Inherited cases do exist, however. The familial case involving brachydactyly type E and short stature without intellectual disability demonstrated that a parent can carry a 2q37.3 deletion, experience only mild skeletal effects, and pass the deletion to a child.7PubMed. The first familial case of inherited 2q37.3 interstitial deletion with isolated skeletal abnormalities including brachydactyly type E and short stature The inherited case from the genotype-phenotype correlation study similarly showed a mother with learning difficulties and mild facial features passing a small deletion to her son, who then had a more complex presentation.3Cytogenetic and Genome Research. Genotype-Phenotype Correlation of Distal 2q37 Deletions These familial cases are a reminder that parental testing after a child is diagnosed is important. A parent who has always been told they were just “short” or who struggled mildly in school may actually carry the same deletion.
Complex chromosomal rearrangements can also produce 2q37 deletions. In one case, a deletion at the tip of chromosome 2 was combined with a large inverted duplication on the same chromosome, creating a more complicated genetic picture than a straightforward terminal deletion.15BioMed Central / PubMed Central. Array-CGH in patients with Kabuki-like phenotype: identification of two patients with complex rearrangements including 2q37 deletions and no other recurrent aberration These complex rearrangements can make it harder to predict the clinical outcome based on deletion size alone and may require more detailed cytogenetic analysis to fully characterize.
Living with the Syndrome as Children Grow
For families navigating daily life, the behavioral features are often the most challenging dimension. The high rate of autism spectrum traits means that many children benefit from behavioral therapies and structured environments. Sleep difficulties, attention problems, and sensory sensitivities are commonly reported by parents, though these are not always captured in clinical literature focused on dysmorphology. Connecting with other families through rare disease networks can be a valuable source of practical strategies and emotional support, since most pediatricians will see few or no cases in their careers.
Seizures represent a later-onset concern that families should be aware of. While not present in all children, they are described as a feature that can emerge beyond the newborn and infant period. Families should know what seizures can look like in their child’s age group so they can report concerns promptly. Similarly, cystic kidneys may not be evident at initial screening but can develop over time, which argues for periodic renal imaging rather than a single baseline study.
Educational planning is another area where the diagnosis can be directly useful. Because intellectual disability in 2q37 deletion syndrome spans a wide range, a well-documented genetic diagnosis paired with developmental testing helps schools build appropriate individualized education plans. Some children with the syndrome attend mainstream classrooms with support, while others benefit from specialized settings. The variability is real, and families should resist the temptation to assume either the best or worst case based on the diagnosis alone. Each child’s own developmental trajectory, tracked over time with regular assessments, is a better guide than any generalization about the syndrome.